Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Acrivon Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +3 vs. Q2 2023
- Shares held
- 15.1M
- −32.7K (−0.2%) vs. Q2 2023
- Total value
- $144.3M
- −$51.7M (−26.4%) vs. Q2 2023
- New holders
- 4
- 15 more added
- Sold out
- 1
- 12 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,810,508 | $46.0M | 0.91% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $28.8M | 0.97% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 1,652,605 | $15.8M | 4.67% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,650,457 | $15.8M | 0.02% | +8110.0% | Added |
| Wellington Management Group LLP | 888,130 | $8.49M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 597,469 | $5.71M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 528,760 | $5.05M | 0.00% | −4,595−0.9% | Reduced |
| Vanguard Group Inc | 468,407 | $4.48M | 0.00% | +65,132+16.2% | Added |
| NEA Management Company, LLC | 430,252 | $4.11M | 0.32% | −51,425−10.7% | Reduced |
| Federated Hermes, Inc. | 226,375 | $2.16M | 0.01% | −78,036−25.6% | Reduced |
| Geode Capital Management, LLC | 189,559 | $1.81M | 0.00% | +11,106+6.2% | Added |
| State Street Corp | 133,276 | $1.27M | 0.00% | +7,300+5.8% | Added |
| UBS Oconnor LLC | 105,000 | $1.00M | 0.02% | +5,000+5.0% | Added |
| DAFNA Capital Management LLC | 76,852 | $734.7K | 0.23% | 00.0% | Unchanged |
| Northern Trust Corp | 72,722 | $695.2K | 0.00% | +4,044+5.9% | Added |
| Charles Schwab Investment Management Inc | 67,661 | $646.8K | 0.00% | +6,703+11.0% | Added |
| D. E. Shaw & Co., Inc. | 46,750 | $446.9K | 0.00% | −160−0.3% | Reduced |
| JPMorgan Chase & Co | 26,572 | $254.0K | 0.00% | +19,645+283.6% | Added |
| Bank of New York Mellon Corp | 24,795 | $237.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 14,100 | $134.8K | 0.00% | −163−1.1% | Reduced |
| Nuveen Asset Management, LLC | 11,821 | $113.0K | 0.00% | 00.0% | Unchanged |
| AAFCPAs Wealth Management, LLC | 10,678 | $102.1K | 0.07% | 00.0% | Unchanged |
| Exchange Traded Concepts, LLC | 9,919 | $94.8K | 0.00% | −1,790−15.3% | Reduced |
| Rhumbline Advisers | 9,477 | $90.6K | 0.00% | +491+5.5% | Added |
| Bank of America Corp | 9,332 | $89.2K | 0.00% | +1,708+22.4% | Added |
| Morgan Stanley | 4,943 | $47.3K | 0.00% | −3,562−41.9% | Reduced |
| American International Group, Inc. | 4,338 | $41.5K | 0.00% | +155+3.7% | Added |
| New York State Common Retirement Fund | 2,297 | $22.0K | 0.00% | +22+1.0% | Added |
| Wells Fargo & Company | 2,161 | $20.7K | 0.00% | −1,144−34.6% | Reduced |
| California State Teachers Retirement System | 1,918 | $18.3K | 0.00% | −973−33.7% | Reduced |
| Royal Bank of Canada | 1,561 | $15.0K | 0.00% | +654+72.1% | Added |
| Allspring Global Investments Holdings, LLC | 1,564 | $15.0K | 0.00% | +1,564 | New |
| Amalgamated Bank | 1,344 | $13.0K | 0.00% | +563+72.1% | Added |
| Tower Research Capital LLC (TRC) | 1,255 | $12.0K | 0.00% | +523+71.4% | Added |
| Legal & General Group Plc | 839 | $8.02K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 800 | $7.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 695 | $6.64K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 288 | $2.75K | 0.00% | −134−31.8% | Reduced |
| Citigroup Inc | 230 | $2.20K | 0.00% | −2,560−91.8% | Reduced |
| Qube Research & Technologies Ltd | 138 | $1.32K | 0.00% | +138 | New |
| UBS Group AG | 102 | $975 | 0.00% | −9,678−99.0% | Reduced |
| Toronto Dominion Bank | 41 | $392 | 0.00% | +41 | New |
| Nisa Investment Advisors, LLC | 12 | $115 | 0.00% | +12 | New |
| Deutsche Bank AG | 0 | $0 | 0.00% | −4,062−100.0% | Sold out |